BCTG Acquisition Corp. (BCTG)
Stock Price:
$10.30 USD
-0.04 (-0.39%)
Updated November 23, 4:00 PM EST - Market closed
Key Info
| Market Cap |
220.19M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
n/a |
| Shares Out |
16.08M |
| EPS (ttm) |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
November 23 |
| Last Price |
$10.30 |
| Previous Close |
$10.34 |
| Change ($) |
-0.04 |
| Change (%) |
-0.39% |
| Day's Open |
10.60 |
| Day's Range |
10.26 - 10.73 |
| Day's Volume |
12,200 |
| 52-Week Range |
9.83 - 10.88 |
More Stats
| Market Cap |
220.19M |
| Enterprise Value |
220.19M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
16.08M |
| Float |
n/a |
| EPS (basic) |
n/a |
| EPS (diluted) |
n/a |
| FCF / Share |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
974 |
| Short Ratio |
0.13 |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
8,976.91 |
| Revenue |
n/a |
| Operating Income |
n/a |
| Net Income |
n/a |
| Free Cash Flow |
n/a |
| Net Cash |
-32 |
| Net Cash / Share |
0.00 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Overview
No financial data available for this stock yet.
Company Details
| Full Name |
BCTG Acquisition Corp. |
| Country |
United States |
| CEO |
Aaron I. Davis |
Stock Information
| Ticker Symbol |
BCTG |
| Stock Exchange |
NASDAQ |
| Sector |
Financial Services |
| Industry |
Shell Companies |
| Unique Identifier |
NASDAQ: BCTG |
| IPO Date |
September 3, 2020 |
Description
BCTG Acquisition Corp. is a newly organized blank check company incorporated in May 2020 as a Delaware corporation formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on innovative companies in the biotechnology sector in North America and Europe in order to most effectively leverage our management team’s background and expertise.